A FUNCTIONAL P53-RESPONSIVE INTRONIC PROMOTER IS CONTAINED WITHIN THE HUMAN MDM2 GENE

被引:249
作者
ZAUBERMAN, A [1 ]
FLUSBERG, D [1 ]
HAUPT, Y [1 ]
BARAK, Y [1 ]
OREN, M [1 ]
机构
[1] WEIZMANN INST SCI,DEPT CHEM IMMUNOL,IL-76100 REHOVOT,ISRAEL
关键词
D O I
10.1093/nar/23.14.2584
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The mdm2 gene is a target for transcriptional activation by the p53 tumor suppressor gene product, Previous work has revealed that the mouse mdm2 gene contains two promoters: one is located upstream to the gene and is active in the absence of p53, the other resides within the first intron and requires p53 for transcriptional activity, To determine whether this unique promoter activation pattern is biologically important, we investigated the structure and function of the corresponding region of the human mdm2 (hmdm2) gene. We report here that the hmdm2 gene also contains an intronic, p53-dependent promoter, The structural features of this promoter are highly conserved between mouse and man, as opposed to the lack of conservation of the first exon, This promoter is triggered in vivo in the presence of activated wild type p53, leading to the production of novel mRNA species. The intronic hmdm2 promoter contains two tandem p53 binding elements, Deletion analysis suggests that optimal promoter activity requires the simultaneous binding of p53 to both elements; this may serve to prevent premature triggering of the promoter by p53.
引用
收藏
页码:2584 / 2592
页数:9
相关论文
共 36 条
  • [1] MDM2 EXPRESSION IS INDUCED BY WILD TYPE-P53 ACTIVITY
    BARAK, Y
    JUVEN, T
    HAFFNER, R
    OREN, M
    [J]. EMBO JOURNAL, 1993, 12 (02) : 461 - 468
  • [2] ENHANCED BINDING OF A 95-KDA PROTEIN TO P53 IN CELLS UNDERGOING P53-MEDIATED GROWTH ARREST
    BARAK, Y
    OREN, M
    [J]. EMBO JOURNAL, 1992, 11 (06) : 2115 - 2121
  • [3] INTERACTIONS BETWEEN P53 AND MDM2 IN A MAMMALIAN-CELL CYCLE CHECKPOINT PATHWAY
    CHEN, CY
    OLINER, JD
    ZHAN, QM
    FORNACE, AJ
    VOGELSTEIN, B
    KASTAN, MB
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (07) : 2684 - 2688
  • [4] REGULATION OF TRANSCRIPTION FUNCTIONS OF THE P53 TUMOR-SUPPRESSOR BY THE MDM-2 ONCOGENE
    CHEN, JD
    LIN, JY
    LEVINE, AJ
    [J]. MOLECULAR MEDICINE, 1995, 1 (02) : 142 - 152
  • [5] CORDONCARDO C, 1994, CANCER RES, V54, P794
  • [6] DONEHOWER LA, 1983, BIOCHIM BIOPHYS ACTA, V1155, P181
  • [7] DEFINITION OF A CONSENSUS BINDING-SITE FOR P53
    ELDEIRY, WS
    KERN, SE
    PIETENPOL, JA
    KINZLER, KW
    VOGELSTEIN, B
    [J]. NATURE GENETICS, 1992, 1 (01) : 45 - 49
  • [8] WAF1, A POTENTIAL MEDIATOR OF P53 TUMOR SUPPRESSION
    ELDEIRY, WS
    TOKINO, T
    VELCULESCU, VE
    LEVY, DB
    PARSONS, R
    TRENT, JM
    LIN, D
    MERCER, WE
    KINZLER, KW
    VOGELSTEIN, B
    [J]. CELL, 1993, 75 (04) : 817 - 825
  • [9] WILD-TYPE P53 CAN INHIBIT ONCOGENE-MEDIATED FOCUS FORMATION
    ELIYAHU, D
    MICHALOVITZ, D
    ELIYAHU, S
    PINHASIKIMHI, O
    OREN, M
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (22) : 8763 - 8767
  • [10] P53-DEPENDENT REPRESSION OF CDK4 TRANSLATION IN TGF-BETA-INDUCED G(1) CELL-CYCLE ARREST
    EWEN, ME
    OLIVER, CJ
    SLUSS, HK
    MILLER, SJ
    PEEPER, DS
    [J]. GENES & DEVELOPMENT, 1995, 9 (02) : 204 - 217